← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2007Last known activity
Apr 1, 2022
Timeline
2000s
- Jun 1, 2004
Diurnal Limited— Founded
Drugs by trial phase (4 distinct, 19 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT05299554Lead sponsorPhase 3Apr 1, 2022
- NCT05063994Lead sponsorPhase 3Nov 30, 2021
- NCT05222152Lead sponsorPhase 2Nov 23, 2021
- NCT05222152Overall official - principal investigatorPhase 2Nov 23, 2021
- NCT03532022Study directorPhase 3Sep 30, 2018
- NCT03532022Lead sponsorPhase 3Sep 30, 2018
- NCT03311932Lead sponsorPhase 1Apr 16, 2018
- NCT03343327Lead sponsorPhase 1Feb 19, 2018
- NCT03178214Lead sponsorPhase 1Jun 1, 2017
- NCT02966652Lead sponsorPhase 1Sep 1, 2016
- NCT03062280Lead sponsorPhase 3Aug 1, 2016
- NCT02733367Lead sponsorPhase 3Mar 1, 2016
- NCT02716818Lead sponsorPhase 3Feb 1, 2016
- NCT02720952Lead sponsorPhase 3Mar 1, 2015
- NCT02408068Lead sponsorPhase 1Jan 1, 2015
Details
- Founded
- Cardiff, GB Jun 1, 2004
- Last known activity
- Apr 1, 2022